InspectIR Featured in Yahoo Business

This Breath Test Can Detect Whether You Have COVID-19 in Just 3 Minutes

Rapid testing for COVID-19 has become part of many Americans’ lives since late 2021, but now, a new COVID-19 breath test might make it even more convenient to get tested. On Thursday, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization for the first COVID-19 breath test that can detect chemical compounds associated with SARS-CoV-2 in just three minutes. According to the FDA, the InspectIR COVID-19 Breathalyzer is around the size of a “piece of carry-on luggage,” and can be used in locations where the patient’s sample is collected and analyzed by a qualified health care provider authorized to prescribe tests, like hospitals, mobile testing sites, and doctor’s offices.

But how accurate will the results be? The COVID-19 breath test was used in a study of 2,409 patients, a group that included those with and without COVID-19 symptoms. The breathalyzer correctly identified 91% of positive samples and 99% of negative samples. In a follow-up clinical study, the tool correctly detected the omicron variant with similar levels of accuracy. Research has found that rapid antigen tests correctly identified 93% of positive samples and 99% of negative samples, so in this sense, the breathalyzer and rapid antigen tests have similar levels of accuracy.


We are excited about the future of work…and know that InspectIR and our instrument can help alleviate some of your fears.  If you are interested in learning more, please call 469.206.4555 or write

Leave a Reply

Your email address will not be published. Required fields are marked *